RxDoctor Payments Data

Ernest Pugh, MD

Family Medicine · Charlottesville, VANPI 1831163575

Payments from drug & device makers

$1,261in general payments, 2019–2025

Across 82 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$275
  • Novo Nordisk$177
  • Johnson & Johnson$149
  • Amarin Pharma, Inc.$103
  • Amgen$81
  • Merck$74
  • plus $402 from 13 others

What the payments were for

  • Food & beverage$1,24499%
  • Education$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,261 in reported general payments places this provider in the 70th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$1,278
Medicare patients
65
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$39,118
OzempicSemaglutide20$34,094
FarxigaDapagliflozin Propanediol17$20,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$19,808
BriviactBrivaracetam13$18,516
JardianceEmpagliflozin15$13,722
LinzessLinaclotide13$10,913
Tresiba Flextouch U-200Insulin Degludec11$9,396
Risperidone17$2,358
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,063
Albuterol Sulfate HfaAlbuterol Sulfate42$1,778
Duloxetine Hcl70$1,514
Levetiracetam15$1,118
Montelukast Sodium65$1,097
Omeprazole81$1,095

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$70$39,11838 claims
Novo NordiskOzempic$177$34,09420 claims
AstraZenecaFarxiga$275$20,83417 claims
GSKTrelegy Ellipta$39$19,80812 claims
Boehringer IngelheimJardiance$33$13,72215 claims
ANI Pharmaceuticals, Inc.Valsartan$26$58421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →